These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3528331)

  • 1. Immune reconstitution post-bone marrow transplantation.
    Gelfand EW
    Int J Cell Cloning; 1986; 4 Suppl 1():19-25. PubMed ID: 3528331
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine does not prevent in vivo expression of T cell activation antigens following allogeneic bone marrow transplantation.
    Forman SJ; Gallagher MT; Zaia JA; Wright C; Blume KG
    Transplantation; 1984 Feb; 37(2):219-20. PubMed ID: 6420961
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyclosporin A].
    Gabrielli A; Rupoli S
    Recenti Prog Med; 1985 Jun; 76(6):326-31. PubMed ID: 3903888
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.
    Auletta JJ; Devecchio JL; Ferrara JL; Heinzel FP
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):834-47. PubMed ID: 15570252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
    Teshima T; Mach N; Hill GR; Pan L; Gillessen S; Dranoff G; Ferrara JL
    Cancer Res; 2001 Jan; 61(1):162-71. PubMed ID: 11196155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation.
    Giebel S; Dziaczkowska J; Wysoczanska B; Wojnar J; Krawczyk-Kulis M; Lange A; Holowiecki J
    Bone Marrow Transplant; 2007 Oct; 40(7):705-6. PubMed ID: 17680024
    [No Abstract]   [Full Text] [Related]  

  • 10. FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.
    Blazar BR; Taylor PA; Fitzsimmons WE; Vallera DA
    J Immunol; 1994 Aug; 153(4):1836-46. PubMed ID: 7519216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte subpopulations identified by monoclonal antibodies after human bone-marrow transplantation.
    Tubiana N; Maraninchi D; Mawas C; Lecaer F; Sainty D; Sebahoun G; Olive D; Gastaut JA; Carcassonne Y
    Pathol Biol (Paris); 1985 Mar; 33(3):173-8. PubMed ID: 3892443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease.
    Hess AD; Fischer AC; Horwitz L; Bright EC; Laulis MK
    J Immunol; 1994 Jul; 153(1):400-11. PubMed ID: 8207251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.
    Gaschet J; Mahé B; Milpied N; Devilder MC; Dréno B; Bignon JD; Davodeau F; Hallet MM; Bonneville M; Vié H
    J Clin Invest; 1993 Jan; 91(1):12-20. PubMed ID: 8423212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine inhibits interleukin-2 production during human cellular immune response to pig antigens.
    Pozzetto U; Citterio F; Fioravanti G; Tassoni S; Serino F; Caizzi MP; Castagneto M
    Transplant Proc; 1994 Oct; 26(5):2869-70. PubMed ID: 7940906
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular modulation of acute graft-vs.-host disease.
    Colby C; Sykes M; Sachs DH; Spitzer TR
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):287-93. PubMed ID: 9502295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
    Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
    Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity of T lymphocytes and hematopoietic precursor cells to photochemotherapy with 8-methoxypsoralen and ultraviolet A light.
    Mabed M; Coffe C; Racadot E; Angonin R; Pavey JJ; Tiberghien P; Herve P
    Ann Hematol; 2006 Jan; 85(1):17-24. PubMed ID: 16208471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT; Li SN; Champlin RE; Gale RP
    Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.